Note: Ingredients listed on restricted chemical lists
General Information
Version
3.01
Revision date
2021-04-19
Product name
Acetone
1.2.1 Relevant identified uses
Paint or paint related material
1.2.2. Uses advised against
Industrial use only
supplier name
Valspar B.V
Icons in SDS
Company Information
company name
Valspar B.V
e-mail address of the competent person responsible for the Safety Data Sheet
sds@sherwin.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H225, H319, H336
Hazard statements
Code
Statements
H225
Highly Flammable liquid and vapour
Section 2
SECTION 2: Hazards identification
1272/2008] Classification of the substance or mixture
Product definition
Mixture
2.2 Label elements
R6K9
Signal word
Danger
Hazard statements
Highly flammable liquid and vapor. Causes serious eye irritation. May cause drowsiness or dizziness.
Prevention
Wear eye or face protection. Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking. Avoid breathing vapor.
Response
IF INHALED: Call a POISON CENTER or doctor if you feel unwell. IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. If eye irritation persists: Get medical advice or attention.
Storage
Not applicable.
Disposal
Not applicable.
Hazardous Ingredients
Acetone
Supplemental label elements
FOR INDUSTRIAL USE ONLY
Annex XVII - Restrictions on the manufacture, placing on the market and use of certain dangerous substances, mixtures and articles
Not applicable.
Special packaging requirements
Not applicable.
2.3 Other hazards
This mixture does not contain any substances that are assessed to be a PBT or a vPvB.
Other hazards which do not result in classification
None known.
2.1 Classification of the substance or mixture
Product definition : Mixture Classification according to Regulation (EC) No. 1272/2008 [CLP/GHS] Flam. Liq. 2, H225 Eye Irrit. 2, H319 STOT SE 3, H336 The product is classified as hazardous according to Regulation (EC) 1272/2008 as amended. See Section 16 for the full text of the H statements declared above. See Section 11 for more detailed information on health effects and symptoms.
